49,277
edits
Difference between revisions of "Neuroendocrine markers"
Jump to navigation
Jump to search
Neuroendocrine markers (view source)
Revision as of 20:21, 2 September 2025
, 20:21, 2 September 2025no edit summary
| Line 9: | Line 9: | ||
===Less common markers=== | ===Less common markers=== | ||
*INSM1 (Insulinoma-associated Protein 1).<ref>{{cite journal |authors=Sakakibara R, Kobayashi M, Takahashi N, Inamura K, Ninomiya H, Wakejima R, Kitazono S, Yanagitani N, Horiike A, Ichinose J, Matsuura Y, Nakao M, Mun M, Nishio M, Okumura S, Motoi N, Ito T, Miyazaki Y, Inase N, Ishikawa Y |title=Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56 |journal=Am J Surg Pathol |volume=44 |issue=6 |pages=757–764 |date=June 2020 |pmid=32118626 |doi=10.1097/PAS.0000000000001444 |url=}}</ref> | |||
*NSE. | *NSE. | ||
*CD57. | *CD57. | ||
* | *PGP9.5. | ||
==See also== | ==See also== | ||